MENU
+Compare
MIRM
Stock ticker: NASDAQ
AS OF
Apr 4, 12:58 PM (EDT)
Price
$41.95
Change
-$1.28 (-2.96%)
Capitalization
2.12B

MIRM Mirum Pharmaceuticals Forecast, Technical & Fundamental Analysis

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases... Show more

MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MIRM with price predictions
Apr 03, 2025

MIRM's Stochastic Oscillator is sitting in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MIRM's RSI Indicator exited the oversold zone, of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MIRM advanced for three days, in of 305 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MIRM as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MIRM turned negative on April 01, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

MIRM moved below its 50-day moving average on March 21, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MIRM crossed bearishly below the 50-day moving average on March 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIRM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MIRM broke above its upper Bollinger Band on March 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MIRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.390) is normal, around the industry mean (13.581). P/E Ratio (0.000) is within average values for comparable stocks, (64.662). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.879). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (6.098) is also within normal values, averaging (248.206).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MIRM is expected to report earnings to fall 83.28% to -30 cents per share on May 01

Mirum Pharmaceuticals MIRM Stock Earnings Reports
Q1'25
Est.
$-0.31
Q4'24
Missed
by $1.55
Q3'24
Beat
by $0.15
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.12
The last earnings report on February 26 showed earnings per share of -185 cents, missing the estimate of -30 cents. With 94.25K shares outstanding, the current market capitalization sits at 2.12B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSDGX20.40N/A
N/A
Victory RS Select Growth A
FBAKX29.00N/A
N/A
Fidelity Balanced K
PALRX17.17N/A
N/A
PGIM Balanced R
JVTNX79.65N/A
N/A
Janus Henderson Venture N
SCIZX7.30N/A
N/A
Virtus SGA International Growth R6

MIRM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with GERN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then GERN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRM
1D Price
Change %
MIRM100%
-3.93%
GERN - MIRM
41%
Loosely correlated
-7.55%
FHTX - MIRM
36%
Loosely correlated
-7.89%
CYCC - MIRM
36%
Loosely correlated
-6.20%
VCYT - MIRM
35%
Loosely correlated
-5.51%
RARE - MIRM
34%
Loosely correlated
-0.68%
More